Warfarin no better than aspirin in patients with heart failure

mdCurrent Conference Report: International Stroke Conference Warfarin did not reduce the rate of the combined endpoint of death, ischemic stroke, or intracerebral hemorrhage compared with aspirin, according to a Late Breaking Clinical Trial presented at the 2012 International Stroke Conference. Both warfarin and aspirin are used in this clinical setting,… 

Read more »
Posted in Cardiology, Cardiovascular, Cardiovascular Disease, Neurology, Non-Communicable Disease, Pharmacology, Primary Care | Tagged , , , , , , , , , , , , | Volume: | Leave a comment

Meta-analysis examines whether aspirin is worth the risk for primary prevention

Despite clinically relevant reductions in nonfatal myocardial infarction (MI), the use of aspirin in patients without a history of cardiovascular disease (CVD) does not lead to reductions in either cardiovascular- or cancer-related death, according to a recently published meta-analysis. The incidence of CVD in India is on the rise and… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Pharmacology | Tagged , , , , , , , , , | Volume: | Leave a comment

Chest pain often absent in young women with myocardial infarction

Women with myocardial infarction (MI) are more likely to present without chest pain than men. Younger women without chest pain as a presenting feature of MI are also more likely to die in the hospital compared with their male counterparts, although this effect diminishes with age. Key Point: Women with… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Primary Care, Women's Health | Tagged , , , , , , , , | Volume: | Leave a comment

Not all oral type 2 diabetes medications are created equally; advice for starting monotherapy

While all of the oral medications approved to treat type 2 diabetes mellitus (T2DM) effectively lower blood glucose, each medication’s effects on other clinical events vary. The costs of these drugs also vary. A recent study of 254,973 T2DM patients who were newly initiated on oral hypoglycemic monotherapy examined prescribing… 

Read more »
Posted in Diabetes, Endocrinology, Non-Communicable Disease, Pharmacology, Primary Care | Tagged , , , , , , , , , , , , | Volume: | Leave a comment

Lifetime risk for cardiovascular disease is tied to blood pressure changes at age 55

Blood pressure changes in middle age correlate with the remaining lifetime risk of cardiovascular disease (CVD), according to the results from a pooled analysis of 7 studies. In the analysis of the U.S.-based studies, people with an increase in blood pressure in middle age had an increase in the remaining… 

Read more »
Posted in Cardiology, Cardiovascular Disease, Geriatrics, Hypertension, Primary Care | Tagged , , , , , , , , , , , | Volume: | Leave a comment

Study results make the case for quick titration of antihypertensive drugs to lower blood pressure

Patients who take their blood pressure (BP) medication as prescribed can reach maximum BP efficacy within a few weeks of starting therapy, according to a recent meta-analysis. Knowing this early can help you determine whether a new BP medication is working or not, so that you can try another agent… 

Read more »
Posted in Hypertension, Pharmacology, Primary Care | Tagged , , , , , , , , , | Volume: | Leave a comment

Childhood obesity leads to adverse cardiovascular and metabolic consequences as adults

Childhood obesity, a growing problem in India, compromises future cardiovascular health, according to a Canadian researcher in population health, who authored a review on the link between childhood obesity and adverse health outcomes in the Indian Journal of Endocrinology and Metabolism. According to data published in the late 2000s, the… 

Read more »
Posted in Cardiovascular Disease, Non-Communicable Disease, Obesity, Pediatrics | Tagged , , , , , , , , | Volume: | Leave a comment